| Financial Year |
March 31 2023 |
| Monetary Funds |
3,815,781,532.25 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
948,719,720.52 |
| Advances to Suppliers |
21,455,866.58 |
| Other Receivables |
80,270,252.13 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
153,913,402.86 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
17,378,044.14 |
| Total Current Assets |
5,330,629,413.93 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
433,135,978.14 |
| Investment Properties |
1,005,038,700.00 |
| Fixed Assetes |
5,527,732,543.96 |
| Under-construction Projects |
1,212,461,082.61 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
342,805,316.00 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
7,575,922.05 |
| Deferred Income Tax Assets |
161,184,151.86 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
8,696,225,623.29 |
| Total Assets |
14,026,855,037.22 |
| Short-Term Loans |
2,441,930,560.50 |
| Trading Financial liabilities |
-- |
| Notes Payable |
4,406,710,000.00 |
| Accounts Payable |
1,254,502,060.05 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
558,363,444.51 |
| Taxes Payable |
111,838,433.04 |
| Interest Payable |
-- |
| Dividend Payable |
324,290,320.67 |
| Other payables |
1,163,763,656.99 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,876,190.48 |
| Other Current Liabilities |
35,002,433.92 |
| Sub-Total of Current Liabilities |
10,266,280,846.16 |
| Long-term Loans |
110,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
695,030,975.84 |
| Deferred Income Tax Liabilities |
123,631,935.33 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
936,042,504.36 |
| Total Liabilities |
11,202,323,350.52 |
| Paid-In Capital(Or Share Stock) |
1,218,412,038.00 |
| Capital Surplus |
227,418,465.67 |
| Surplus Reserve |
429,197,595.90 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-590,967,803.21 |
| Minority Stockholder's Interest |
1,096,447,901.81 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,728,083,784.89 |
| Owner's Equity（Stockholder's Equity） |
2,824,531,686.70 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
14,026,855,037.22 |
